List view / Grid view
The National Institute of Allergy and Infectious Diseases (NIAID)-supported clinical…
The National Institute of Allergy and Infectious Diseases (NIAID)-supported clinical trial will assess whether the bacteriophage therapy WRAIR-PAM-CF1 safely reduces the quantity of Pseudomonas aeruginos bacteria in fibrocystic lungs.
Zoliflodacin was found to be effective in curing all rectal…
Zoliflodacin was found to be effective in curing all rectal gonorrheal infections in patients during a Phase II clinical trial...
Scientists developed monoclonal antibody from Ebola survivor...
Scientists developed monoclonal antibody from Ebola survivor...
Topical treatment with live Roseomonas mucosa was found to be safe…
Topical treatment with live Roseomonas mucosa was found to be safe for adults and children with atopic dermatitis...
Two new clinical trials testing an experimental vaccine to prevent…
Two new clinical trials testing an experimental vaccine to prevent influenza caused by an H7N9 influenza virus are now enrolling volunteers at sites across the United States...
Broadly neutralising antibody treatment may target viral reservoir in monkeys...
Broadly neutralising antibody treatment may target viral reservoir in monkeys...
Clinical trial will compare three antiretroviral drug regimens...
Clinical trial will compare three antiretroviral drug regimens...
Clinical trial results show that two candidate Ebola vaccines can…
Clinical trial results show that two candidate Ebola vaccines can elicit immune responses after initial vaccination that last for at least one year...
